Member Info for djmmac

Please excuse my ignorance. is todays RNS in relation to the RNS a few days ago about the AAA who folk have touted as being EA?

Is todays RNS just a Starter in the feast to come?

Fantastic news. Good luck all

Why does it take so bl@@dy long to get tests approved and how come the Chinese tests have been on the market for almost two years?? Did they take 18 months to get approval? I think not....

?

I wouldn’t be banking on uk gov for any support even with world beating results. Some folk say unless you come from Oxford or have a Tory peer on your board then you’ve no chance. Just look how NCYT and ODX have been royally shafted by this gov. They don’t appear to give a rats arse if folk get the right treatment as long as we empty our wallets to Pfizer’s coffers, keep Tory chums in the money and sweeten the Chinese by buying their crap tests then some would say the no 10 are well happy. The good news is that there is a big bad world outside the UK who will want their good folk puffing on an SNG pipe with all the good interferons when sick in a hospital bed. Long and strong here.

Can highly recommend Trekmadone’s posts on this thread. One of the most astute investors on the lse bulletin boards. I am expecting some hanky panky in the markets this week and sounds like a full frontal assault is on the way for Synairgen. Every time this has happened before the big boys have been scooping up. Now more than ever the opportunity for Synairgen is massive. No guarantees but I can not imagine that the phase three results will disappoint. Good luck all holders. I won’t be selling a bean.

This shins. You may be concerned and if genuine then don’t be but I suspect you are trying to stir the pot. If you had any understanding of what is being said about the lack of breathless patients then you would not batter an eyelid. Covid doesn’t hospitalise you for a bunch of random medical ailments and those diagnosed by default when admitted for another reason have no bearing on the future need for respiratory treatments for covid. Remember for most people covid is a relatively mild illness and asymptomatic cases occur. Nothing has changed here. We are not looking to treat the asymptomatic

There was a flurry of enormous trades around 12.30. Multi millions pounds over about ten trades. I saw flash up here. Anyone else see that today?

What a load of utter ****e bell.end and co spout. Unreadable nonsense. I guess that is the mo

.

This is a great price to join in. Many investors came on board/invested at the fundraise over a year ago at 175p. They have been sitting on the rollercoaster ever since and rarely in profit. The share is now majorly de-risked compared to any previous point in time. Probability of success and multi billion valuation is high, very high. A multi bagger in the making and in my view worth risking a fair bit of net wealth. I do not think there is a comparable precedent in the biotech sector hence massive undervaluation at current level.

Don’t forget the third being the speeding ticket knowing this Bods previous!! Hope not though….

Sojourner-let’s hope so or major trust issues ….

Look at Synairgen and how they raised at 175p a year ago. Look how Eurasia raised from ii at a premium. They are good examples. Not letting the price drift 22-15 in a month and then raising at a discount. It’s poor form for what was a quality outfit

Rest in Peace JTMacs

Taken too early. A sure reality check for the rest of us here. Real people and part of the EUA family. 68 shares bought.

Let’s put the squeeze on!

A glance at this board and exbrat looks like a de ramping tool

Not sure if this has been posted yet: https://twitter.com/aleksbinkowska/status/1459184050141372422?s=21

This board is infested. Horrendous influx of posters apparently heavily invested but spouting rubbish. The link above is a perfect example

There is no place for online abuse or bullying. These boards reek of it. And it stinks.

Swazers is spot on to call it out. I can guarantee that these keyboard warriors wouldn’t dare repeat the same if stood face to face with their target.